The researchers estimated that people with type 1 diabetes were nearly three times as likely to develop dementia as people without diabetes. People with type 2 diabetes were twice as likely to develop... .
Three major Indian drugmakers have introduced low-cost generic versions of Semaglutide injections following the expiry of its patent, expanding access for patients with Type 2 Diabetes and obesity.
Reddy's Laboratories announces launch of India's first DCGI-approved Semaglutide injection 'Obeda®' for Type 2 Diabetes... 2 diabetes in India ... 1 https.//idf.org/about-diabetes/diabetes-facts-figures/.
One of Eli Lilly & Co.’s most highly anticipated experimental medicines helped diabetic patients lose more weight than any drug currently on the market, underscoring its potential in the increasingly crowded race for next-generation therapies ....